2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

González-Garcinuño, A, Tabernero, A, Blanco-López, M, del Valle, EM, Kenjeres, S. Multi-physics numerical simulation study on thermo-sensitive gel delivery for a local post-tumor surgery treatment. EUR J PHARM SCI 203 -. 1 dic 2024. 1 sep 2024. . F.I.:4,300 [doi:10.1016/j.ejps.2024.106917]
Mottola, Stefania, Viscusi, Gianluca, Gonzalez-Garcinuno, Alvaro, Tabernero, Antonio, Cardea, Stefano, del Valle, Eva M. Martin, Gorrasi, Giuliana, De Marco, Iolanda. Controlling particle size of levan in powder form with different technologies. INT J BIOL MACROMOL 280 -. 1 nov 2024. 1 sep 2024. . F.I.:7,700 [doi:10.1016/j.ijbiomac.2024.135768]
Pelaz, SG, Flores-Hernández, R, Vujic, T, Schvartz, D, Alvarez-Vázquez, A, Ding, YX, García-Vicente, L, Belloso, A, Talaverón, R, Sánchez, JC, Tabernero, A. A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma. TRANSL RES 272 95-110. 1 oct 2024. 1 jun 2024. . F.I.:6,400 [doi:10.1016/j.trsl.2024.06.001]
Alvarez-Vázquez, A, San-Segundo, L, Cerveró-García, P, Flores-Hernández, R, Ollauri-Ibáñez, C, Segura-Collar, B, Hubert, CG, Morrison, G, Pollard, SM, Lathia, JD, Sánchez-Gómez, P, Tabernero, A. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43_266-283 antitumor response in preclinical glioblastoma models. NEURO-ONCOLOGY 26 1230-1246. 20 mar 2024. 1 mar 2024. . F.I.:16,400 [doi:10.1093/neuonc/noae060]